MAPT and Alzheimer disease: Common approaches for diagnosis of AD include structural imaging of brain atrophy using magnetic resonance imaging (MRI), functional MRI (fMRI), imaging of amyloid or tau through positron emission tomography (PET), and the assessment of cerebrospinal fluid (CSF) or blood biomarkers (Dong et al.